The Joint Blog

DECEMBER 2, 2019

CBD could “significantly reduce opioid use and improve chronic pain and sleep quality among patients who are currently using opioids for pain management”, according to a new study. Data were collected at three different time points: baseline, 4, and 8 weeks. Ninety-seven patients completed the 8-week study.

Chronic Pain 68

Chronic Pain Sleep CBD Extraction 68

MedicalJane

JUNE 12, 2020

Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes. A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

The Cannigma

JUNE 30, 2021

To varying degrees, the three most common uses of medical marijuana in Massachusetts, Maine, and Maryland were to treat chronic pain, anxiety, and back and neck problems. of patients reported chronic pain as their primary condition, while in Connecticut 70.4% Severe chronic pain 35,866 30.5% Cancer 5,717 4.9%

Chronic Pain 137

Chronic Pain Marijuana Conditions Patients 137

LifeCannMD

MAY 27, 2025

#image_title By Dr. Fernando Fandio-Sende, LifeCannMD After thirty years practicing medicine and specializing as a Miami cannabis doctor , I’ve had countless conversations with patients who tell me the same thing: “Doctor, I want to try medical marijuana , but I’m scared of getting too high.” hours longer per night.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

LifeCannMD

APRIL 28, 2025

For an engineer like Rick, who understood the value of evidence and data, it was a revelation. “If you knew what I know about this medicine and the people who need it,” he once said, “you’d do the same thing.” When chronic pain has you watching life from the sidelinesit might help you rejoin the game.

History 82

History Chronic Pain Research and Development Oil 82

Cannabis Law Report

AUGUST 10, 2021

Enters into the Chronic Pain Market with Psychedelics. This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. Global Wellness Strategies Inc. ( billion in 2030.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. It seems as though research on cannabis and cannabinoids is taking such large strides that it even surpasses research growth in other fields.

Medicine 81

Medicine Research and Development Data Policy 81

Cannabis Law Report

JULY 20, 2021

Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry. With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”.

Medicine 75

Medicine Business Research and Development Chronic Pain 75

TheAnswerPage

AUGUST 23, 2022

A June 2022 research study conducted in Ontario Canada (where cannabis-based medicine is legal at the federal level), assessed how chronic pain patients view the use of cannabis-based products for medicinal purposes. Do you think that most patients viewed cannabinoid-based therapeutics as an effective pain remedy?

Chronic Pain 75

Chronic Pain Medicine Collective Data 75

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

MAY 19, 2023

The case report built off data self-study complied by an Institute colleague and combined it with past reports of colorblind individuals who experienced vision improvements after consuming psilocybin. Test data showed that the subject experienced peak partial vision improvement around eight days after consuming psilocybin.

Chronic Pain 97

Chronic Pain Data Consumption Safety 97

Sensi Seeds

JANUARY 4, 2019

Context of the Medicinal Cannabis Situation. Under the regulations, no intermediaries are allowed to sell medicinal cannabis to patients. The Canadian medicinal cannabis regime was established in the context of illegal cannabis use. It allows patients to have access to medicinal cannabis without danger of being criminalized.

Medicine 75

Medicine Research and Development Patients Programs 75

The Cannigma

JULY 1, 2021

The study was developed by People Science , a tech-enabled science company that is focused on connecting “health minded people, research scientists, and healthcare providers in an effort to unlock the potential of alternative medicines,” according to People Science. One of the tools to try to tackle sleep and wellness”.

Sleep 119

Sleep Edibles Research and Development Data 119

Veriheal

APRIL 23, 2024

California was the first state to legalize medicinal cannabis in 1996, right around the time that Gen Z began to enter society. Alternative medicines are a priority among Gen Z, who are moving away from traditional Western options and instead using natural wellness to support the mind and body.

Chronic Pain 111

Chronic Pain Data Edibles Sleep 111

Project CBD

MAY 3, 2023

She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain. I don’t know that it’s a direct sleep agent, but when you are having less anxiety and less pain you likely will fall asleep a little bit easier and maybe sleep better.

Cannabinoids 216

Cannabinoids Sleep Clinical Trials CBD 216

Veriheal

AUGUST 22, 2022

Alongside a team of researchers, he will assess 1,000 participants who have been actively consuming opioids for pain relief for a minimum of three months. We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live study. milligrams.

Clinical Trials 116

Clinical Trials Chronic Pain Hydroponic Strains 116

Veriheal

APRIL 11, 2024

This data aligns with Americans’ rising acceptance of cannabis. Now, more than 90% of citizens believe that the substance should be legal for medicinal and recreational use, something that would have seemed astonishing even a mere decade ago. The study also analyzed peoples’ reasons for registering.

Patients 111

Patients Chronic Pain Marijuana Conditions 111

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. The use of cannabis as a therapeutic and medicinal aid is widely supported.

Consumption 111

Consumption Patients Research and Development Data 111

Cannabis Law Report

JULY 13, 2021

Inhalation of cannabis extracts allows for a faster onset and higher bioavailability than tinctures and oils, and now that doctors can monitor a patient’s metered-dosage, more accurate patient data. Patients can now take their medicine without inhaling soot, tar and carcinogens into the lungs.

Extraction 105

Extraction Vaping Medicine Patients 105

Cannabis Law Report

AUGUST 27, 2021

Science and medicine are the basis of Delic’s approach to psychedelic wellness and our experienced and diverse Medical Advisory Board will help ensure our commitment to safety, quality and efficacy of treatments,” said Delic CEO Matt Stang. Chris Ray , PhD : Interventional Pain Physician.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

AUGUST 24, 2022

Results from the third Cannabis as Medicine study. The third Cannabis as Medicine Survey (CAMS20) follows on from CAMS16 and CAMS18, and includes 1,600 people using medical cannabis between September 2020 and January 2021. More work is required to enhance health provider education regarding medicinal cannabis. 25 August 2022.

Medicine 52

Medicine Legalization Chronic Pain Access 52

Project CBD

FEBRUARY 27, 2023

For all modern medicine can do, many mysteries remain unsolved. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.” What is long COVID? Is there really such thing as a “cure” for cancer? That seemed to make all the difference.

THC 144

THC CBD Clinical Trials Sleep 144

The Joint Blog

JULY 14, 2021

Medicinal CBD is helping seniors improve their quality of life. The low THC content ensures that you can reap all its medicinal benefits without having to get high. There has been inadequate research conducted and not enough data that fully supports the use of CBD for the elderly. Some adults over the age of 65 are using CBD.

Medicine 52

Medicine CBD Chronic Pain Oil 52

Cannabis Law Report

MAY 10, 2022

First comprehensive study reveals why Australians take medicinal cannabis. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Improved quality of life.

Cannabinoids 45

Cannabinoids Data Chronic Pain Sleep 45

CannaMD

JULY 23, 2020

In fact, a new study published in the Yale Journal of Biology and Medicine found that cannabis flower may provide near-immediate relief of depression symptoms! Second, this study was conducted as a prospective study in real time, with users reporting data as cannabis use occurred. Depression affects 20% of the U.S. adult population.

Data 114

Data Chronic Pain Patients Sleep 114

LifeCannMD

JANUARY 2, 2025

Clinical Applications Pain Management A systematic review by Whiting analyzed 79 trials and found moderate-quality evidence supporting the use of cannabinoids for chronic pain. A comprehensive review published in JAMA Oncology examined clinical data and case reports on cannabis as an anticancer agent.

Oil 98

Oil Concentrates Treatment Chronic Pain 98

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. “(Cannabis is) also used in conjunction with other medicines, either to improve their efficacy or to mitigate negative side effects. Chronic pain. How is Medical Cannabis Used? Alzheimer’s.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

The Joint Blog

NOVEMBER 4, 2020

According to newly released research which backs up years of previous studies, the medical use of marijuana results in long-term improvements in the conditions of those suffering from chronic pain: This is according to the new study which was published in The European Journal of Pain. 5 Yashar Pain Clinics, Tel-Aviv, Israel.

Chronic Pain 49

Chronic Pain Treatment Marijuana Medicine 49

Veriheal

APRIL 26, 2022

This currency exchange data is provided as a means of assisting industry leaders in making informed business-related decisions. Application: Adult-Use, B2B Avenues, and Medical were studied in-depth for the report, with the latter category being further segmented into Anxiety, Chronic Pain, Inflammation, and Sleep Disorders.

Supply Chain 98

Supply Chain Legalization Research and Development Chronic Pain 98

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Watch how Supera-CBD works. “We

Pharmaceutical 40

Pharmaceutical Data CBD Clinical Trials 40

TheAnswerPage

DECEMBER 6, 2020

The findings of multiple randomized controlled trials (RCTs) indicate that cannabinoids effectively treat chronic pain. Do cannabinoids effectively treat the chronic pain associated with fibromyalgia? See Answer. See Answer.

Chronic Pain 40

Chronic Pain Cannabinoids Pharmaceutical Data 40

TheAnswerPage

JUNE 28, 2020

The findings of multiple RCTs indicate that cannabinoids effectively treat chronic pain. Do cannabinoids effectively treat the chronic pain associated with fibromyalgia? Note: The data from the 2019 study could not be used to extrapolate the long-term effects of cannabinoids on fibromyalgia-associated pain.).

Chronic Pain 40

Chronic Pain Cannabinoids Pharmaceutical Data 40

CannaTech

SEPTEMBER 16, 2018

While Canada’s medicinal cannabis framework has gone through many iterations, Canada has led the way in showing to the world how to think about cannabis. What began as a legal medicine more than 15 years is now being legalized for adult recreational use. The Need for Cannabis Education Tailored to Patient and Doctor.

Education 66

Education Medicine Clinical Trials Patients 66

Cannabis Law Report

NOVEMBER 2, 2021

This updated edition reviews over 450 peer-reviewed studies assessing the safety and efficacy of either whole-plant cannabis or individual cannabinoids in 23 different patient populations, including autism , chronic pain , diabetes , fibromyalgia , migraine , and post-traumatic stress.

Safety 52

Safety Patients Chronic Pain Advocacy 52

Puff Puff Post

SEPTEMBER 16, 2019

. “Patient referrals and training requests from our physician colleagues have increased by more than 500 per cent over the last year,” says Dr. Michael Dworkind, Medical Director of Santé Cannabis and McGill University Associate Professor of Family Medicine. Clinical toolkits to help navigate patient assessment and follow-ups.

Programs 108

Programs Research and Development Education Treatment 108

SpeedWeed

MARCH 9, 2021

Chronic Pain Targeted. Eelco Ockers, Head of Stada, said it wants to focus primarily on the ‘indications of chronic pain , neurology and oncology ‘and that it had been observing the medical cannabis market for some time.

Chronic Pain 52

Chronic Pain Business Pharmaceutical Extraction 52